American Healthcare REIT, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated July 20, 2026, reports significant executive leadership transitions and board appointments for American Healthcare REIT, Inc. (AHR). The filing details the retirement of the long-serving CEO and the subsequent appointment of new leadership effective July 21, 2026.
Key Financial Metrics and Compensation
This filing does not report operational financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The financial data provided relates exclusively to executive compensation packages and severance arrangements:
- Danny Prosky (Retiring CEO): Entitled to a lump sum payment of $35,000 for medical plan continuation expenses and accelerated vesting of unvested Restricted Stock Awards originally scheduled to vest in 2028.
- Jeffrey Hanson (New CEO): Annual base salary of $965,000; target annual bonus of 160% of base salary; time-based RSUs valued at $2,072,534; performance-based RSUs valued at $2,072,534.
- Gabe Willhite (New President & COO): Cash compensation increase of $100,000; target bonus increased to 125% of base; time-based RSUs valued at $347,840; performance-based RSUs valued at $347,840.
- Scott A. Estes (Lead Independent Director): Additional annual cash retainer of $40,000.
Material Changes Versus Prior Period
The primary material change is the departure of Danny Prosky as CEO and President after serving in those roles, with his transition to a non-employee director role. Jeffrey Hanson transitions from Interim CEO to permanent CEO and Chairman of the Board. Gabe Willhite is promoted from Chief Operating Officer to President and Chief Operating Officer. Scott A. Estes is appointed as Lead Independent Director.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of market risks. The primary contingency noted is the vesting of new equity awards for Mr. Hanson and Mr. Willhite, which is subject to their continued service as executive officers or directors through the applicable vesting dates (anniversaries of July 21, 2026, and March 10, 2026, respectively, and a cliff-vesting date of December 31, 2028 for performance awards).
Key Facts for Investor Verification
- Verify the specific terms of the "Release of Claims Agreement" attached as Exhibit 10.1 regarding Mr. Prosky's departure benefits.
- Confirm the performance conditions attached to the $2.07 million in performance-based RSUs granted to Mr. Hanson and the $347,840 granted to Mr. Willhite.
- Review the Company's Definitive Proxy Statement filed on April 9, 2026, for biographical details on the new appointees.
- Note that the press release issued on July 22, 2026, is furnished and not deemed "filed" for liability purposes under Section 18 of the Exchange Act.